There has been a bigger than expected pull back in the SP than most of us were expecting, with a continued couple of big dumps today.
Obviously the market was expecting something to come from the groups looking in the data room and some big players had set themselves up for an outcome from the data room investigations.
We are now back to pre webinar and Goulamina demerger announcement, expectations, with a slightly lower gold price.
We probably need some good gold announcements to turn this around or the sellers with the short term expectations to have completed their sell down. We are back to Goulamina being valued as virtually worthless by the market, so future announcements about whatever deals Macquarie come up with should add significant value, but that is probably a couple of months away.
I have to admit it is also not a good look stating the company had some of the Koting results in, assay results only had a 5-10 day turnaround, Koting drilling had finished weeks ago, but no announcement about them.
- Forums
- ASX - By Stock
- FFX
- Ann: Macquarie appointed to advise on Lithium value Realisation
Ann: Macquarie appointed to advise on Lithium value Realisation, page-103
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online